Building Australia’s future life sciences capital stack: Repeatable success stories
Tuesday, October 21, 2025 |
12:00 PM - 12:30 PM |
Details
Australia produces world-class science, but our capital stack is uneven, surprisingly strong at seed and translation, thin in Series A/B, and shallow at the growth end. Other global hubs once faced the same challenge, in particular, Israel, the UK, Switzerland and Singapore. Each found their own ways to solve it and now have strong capital markets funding innovation.
This panel brings together leading investors, corporates, and financiers to explore what Australia must build locally, what we should rely on globally, and how to ensure our companies scale at home while still connecting to global capital required to catalyse health outcomes.
Speaker
Medard Fischer
VP Strategic Investments Cochlear R&D
Cochlear
Panellist
Rowena Gracey
Director
ARCHIMED
Panellist
Ms Sarah Meibusch
Partner
One-ventures
Panellist
Chris Nave
Founding Partner & Managing Director
Brandon Capital
Panellist
Kerri Lee Sinclair
Head of Investment
AusBiotech
Moderator
